Mckesson Corporation
Research Mckesson Corporation (MCK) on Bullrun: valuation model: 36.2% overvalued, market cap USD 104.99B, P/E 24.2, dividend yield 0.4%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMCK
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Distribution
- CurrencyUSD
- Valuation signal36.2% overvalued
- Market capUSD 104.99B
- P/E24.2
- Dividend yield0.4%
- Financial periodFY2026
- RevenueUSD 403.43B
- Revenue growth12.4%
- Net incomeUSD 4.76B
- Free cash flowUSD 5.72B
- Gross margin3.6%
Valuation Snapshot
Bullrun's latest valuation model marks Mckesson Corporation as 36.2% overvalued; latest market cap is USD 104.99B; P/E is 24.2; dividend yield is 0.4%.
Peer valuation comparison
Latest P/E is 24.22x versus a Healthcare sector median of 24.46x.
Latest dividend yield is 0.37% versus a Healthcare sector median of 2.11% (82.5% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | USD 403.43B | USD 4.76B | USD 5.72B | 3.6% | 38.38 | USD 3.98B | USD 6.53B | -USD 2.17B |
| FY2025 | USD 359.05B | USD 3.30B | USD 5.55B | 3.7% | 25.72 | USD 5.69B | USD 5.65B | -USD 2.07B |
| FY2024 | USD 308.95B | USD 3.00B | USD 3.88B | 4.2% | 22.39 | USD 4.58B | USD 5.63B | -USD 1.97B |
| FY2023 | USD 276.71B | USD 3.56B | USD 4.77B | 4.5% | 25.03 | USD 4.68B | USD 5.59B | -USD 1.86B |
| FY2022 | USD 263.97B | USD 1.11B | USD 4.05B | 5.0% | 7.23 | USD 3.53B | USD 5.88B | -USD 2.27B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 104.99B | 24.2 | 0.4% | 3.28 |
| 2025 | 2025-12-31 | USD 100.90B | 23.6 | 0.4% | 3.06 |
| 2024 | 2024-12-31 | USD 71.77B | 26.1 | 0.5% | 2.66 |
| 2023 | 2023-12-29 | USD 61.61B | 18.3 | 0.5% | 2.32 |
| 2022 | 2022-12-30 | USD 53.19B | 26.6 | 0.5% | 2.02 |
| 2021 | 2021-12-31 | USD 37.24B | 28.0 | 0.7% | 1.78 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 3.28 USD, yield 0.4%.
| Year | Dividends/share |
|---|---|
| FY2026 | 3.17 USD |
| FY2025 | 2.75 USD |
| FY2024 | 2.4 USD |
| FY2023 | 2.09 USD |
| FY2022 | 1.83 USD |
About Mckesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Mckesson Corporation overvalued or undervalued?
Bullrun's valuation model currently marks Mckesson Corporation as 36.2% overvalued.
What is Mckesson Corporation's market cap?
Mckesson Corporation's market capitalization is USD 104.99B.
What is Mckesson Corporation's P/E ratio?
Mckesson Corporation's price-to-earnings (P/E) ratio is 24.2.
Does Mckesson Corporation pay a dividend?
Mckesson Corporation has a dividend yield of 0.4%.
What does Mckesson Corporation do?
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers.